Enright Patrick G's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Nov 9, 2023
- Accession no.
- 0001209191-23-054904
- Filed
- Nov 9, 2023, 8:32 PM ET
- Trade date
- Nov 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Enright Patrick GCIK 0001253886 | 10% Owner |
| Tammenoms Bakker JulietCIK 0001431159 | 10% Owner |
| Longitude Venture Partners IV, L.P.CIK 0001787456 | 10% Owner |
| Longitude Capital Partners IV, LLCCIK 0001829169 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | CConversionAcquired | +1,793,429 | – | – | 1,793,429 | Indirect | |
| Nov 7, 2023 | Common Stock | CConversionAcquired | +319,126 | – | – | 2,112,555 | Indirect | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +454,545 | $11.00 | +$4,999,995 | 2,567,100 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock | CConversionDisposed | −1,793,429 | – | – | 0 | Indirect | |
| Nov 7, 2023 | Common Stock | CConversionDisposed | −319,126 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.